Soleno Therapeutics Inc.

Available to platforms
R StocksTrader
Soleno Therapeutics Inc. (Ticker: SLNOW) is a biopharmaceutical company focused on developing treatments for rare diseases, with a primary emphasis on Prader-Willi syndrome (PWS), a genetic disorder affecting appetite, growth, metabolism, and behavior. Its lead candidate, DCCR (Diazoxide Choline Controlled-Release), is being studied for its potential to address hyperphagia and other symptoms associated with PWS. Soleno continues to advance its clinical programs to provide innovative solutions for unmet medical needs in rare diseases.

Soleno Therapeutics Inc. - SLNOW stocks live chart

Analyze price movements of Soleno Therapeutics Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous SLNOW quotes – including the latest bid at 0.02 USD and ask at 0.05 USD – and get all the necessary information for adding Soleno Therapeutics Inc. to your investment portfolio.

With R StocksTrader, you can invest in Soleno Therapeutics Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Soleno Therapeutics Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of SLNOW does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Soleno Therapeutics Inc. (SLNOW).

You can trade Soleno Therapeutics Inc. (SLNOW) on the R StocksTrader platform.

You can trade online Soleno Therapeutics Inc. (SLNOW) on Prime, ECN, Pro, or R StocksTrader accounts.